Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
US Army
Boehringer Ingelheim
Citi
Express Scripts

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 10,314,855

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,314,855
Title:Methods relating to lung cancer
Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
Inventor(s): Pavel; Ana Brandusa (New York, NY), Campbell; Joshua David (Sharon, MA), Lenburg; Marc Elliott (Brookline, MA), Spira; Avrum (Newton, MA)
Assignee: TRUSTEES OF BOSTON UNIVERSITY (Boston, MA)
Application Number:15/877,447
Patent Claims:see list of patent claims

Details for Patent 10,314,855

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX Orphan search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX search
Eli Lilly And Co CYRAMZA ramucirumab INJECTABLE;INJECTION 125477 002 2014-04-21 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX search
Eli Lilly And Co CYRAMZA ramucirumab INJECTABLE;INJECTION 125477 001 2014-04-21 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
McKinsey
Queensland Health
Fish and Richardson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.